| |
| |
|
| Insider
Information: |
Reed John C |
| Relationship: |
EVP, Innovative Medici... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
14,577 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,266,286 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,577 |
|
|
| Total
Value |
$2,266,286 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Director |
2012-09-06 |
0 |
2012-06-22 |
0 |
Premium* |
|
|
Johnson & Johnson |
JNJ |
EVP, Innovative Medici... |
2024-05-01 |
14,577 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNJ |
Johnson & Johnson |
EVP, Innovative Medicine, R&D |
• – – |
2024-05-01 |
4/A |
D |
$144.59 |
$1,588,177 |
D/D |
(10,984) |
14,577 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Innovative Medicine, R&D |
• – – |
2024-05-01 |
4/A |
OE |
$0.00 |
$0 |
D/D |
25,255 |
25,561 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Innovative Medicine, R&D |
• • – |
2024-05-01 |
4 |
D |
$144.59 |
$1,588,177 |
D/D |
(10,984) |
11,577 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Innovative Medicine, R&D |
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,255 |
22,561 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Pharmaceuticals R&DOffice |
• – – |
2023-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
306 |
|
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-09-06 |
4 |
AS |
$15.18 |
$74,358 |
D/D |
(4,900) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-09-06 |
4 |
OE |
$5.17 |
$25,333 |
D/D |
4,900 |
4,900 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-09-04 |
4 |
AS |
$15.17 |
$77,367 |
D/D |
(5,100) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-09-04 |
4 |
OE |
$5.17 |
$26,367 |
D/D |
5,100 |
5,100 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-07-09 |
4 |
OE |
$3.95 |
$39,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-07-09 |
4 |
AS |
$13.99 |
$139,900 |
D/D |
(10,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-06-22 |
4 |
AS |
$11.06 |
$110,600 |
D/D |
(10,000) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2012-06-22 |
4 |
OE |
$8.15 |
$81,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
